26
Feb 2019
Gene therapy successfully stops most common cause of blindness
A patient in the UK has become the first in the world to undertake gene therapy in an attempt to stop the most common form of blindness in the western world, targeting the underlying genetic cause of age-related macular degeneration (AMD). Around 600,000 people in the UK are currently affected by the condition, where retinal…
